Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Bioatla Inc (BCAB)

Bioatla Inc (BCAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
BioAtla Presents Data from Ongoing Dose Escalation of BA3182, Dual-Conditionally Binding EpCAM x CD3 Bispecific T-cell Engager, in Patients with Treatment Refractory Metastatic Adenocarcinoma at the 2025 European Society for Medical Oncology... GlobeNewswire - Thu Jul 3, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Presents Phase 2 Ozuriftamab Vedotin (Oz-V) Clinical Trial Data Demonstrating Compelling Antitumor Activity in HPV-Associated Oropharyngeal Squamous Cell Carcinoma (HPV+ OPSCC) at the 1.8 mg/kg Q2W dosing regimen GlobeNewswire - Mon Jun 2, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Reports First Quarter 2025 Financial Results and Highlights Recent Progress GlobeNewswire - Tue May 6, 3:05PM CDT

BCAB : 0.3860 (+2.63%)
BioAtla to Participate in the Citizens Life Sciences Conference GlobeNewswire - Wed Apr 30, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla to Announce First Quarter 2025 Financial Results and Provide Business Highlights on May 6, 2025 GlobeNewswire - Tue Apr 29, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Announces Poster Presentations at the 2025 American Association for Cancer Research (AACR) Annual Meeting GlobeNewswire - Thu Apr 24, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Announces Upcoming Poster Presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting GlobeNewswire - Wed Apr 23, 9:05AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress GlobeNewswire - Thu Mar 27, 3:05PM CDT

BCAB : 0.3860 (+2.63%)
BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings GlobeNewswire - Thu Mar 20, 7:00AM CDT

BCAB : 0.3860 (+2.63%)
BioAtla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025 GlobeNewswire - Wed Mar 19, 7:00AM CDT

BCAB : 0.3860 (+2.63%)

Barchart Exclusives

2 ETFs Offering Juicy Dividend Yields of 20% or Higher Barchart - 14 minutes ago
As inflation lingers and rates stay high, investors are flocking to high-yield ETFs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot